Privia Health stockholders re-elect directors, approve executive pay at annual meeting

Filed May 22, 2026 · Period ending May 20, 2026 · ~1 min read

Key Changes

• low

  Stockholders elected three Class I directors (Nancy Cocozza, David King, Francis Soistman) to serve three-year terms expiring in 2029, with all nominees receiving majority support.

  Item 5.07 verify on EDGAR →
• low

  Executive compensation approved on advisory basis with 98% support (103.96M votes for vs. 1.81M against), indicating shareholder satisfaction with management pay practices.

  Item 5.07 verify on EDGAR →
• low

  PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2026 with overwhelming approval (117.34M votes for), confirming continuity in external audit relationship.

  Item 5.07 verify on EDGAR →